Press releases
- Omnicell Supports Global Charity Mercy Ships with Pharmacy Technology Donation
- Omnicell to Present at the BofA Securities 2024 Health Care Conference
- Omnicell Announces First Quarter 2024 Results
- Omnicell Announces XT Amplify
- Omnicell to Release First Quarter 2024 Financial Results on May 2, 2024
- Omnicell to Present at the virtual KeyBanc Annual Life Sciences & MedTech Investor Forum
More ▼
Key statistics
SmartText not available for this item.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | -- |
---|---|
High | -- |
Low | -- |
Bid | -- |
Offer | -- |
Previous close | 3,756.00 |
Average volume | -- |
---|---|
Shares outstanding | 45.92m |
Free float | 45.20m |
P/E (TTM) | -- |
Market cap | 1.50bn USD |
EPS (TTM) | -0.461 USD |
Data delayed at least 20 minutes, as of Dec 30 2021 11:30 GMT.
More ▼